Hyperthermia Cancer Treatment Market Size 2024-2028
The hyperthermia cancer treatment market size is forecast to increase by USD 59 million at a CAGR of 5.9% between 2023 and 2028.
- The market is experiencing significant growth due to the increasing demand for locoregional and whole-body hyperthermia as a complementary therapy in cancer management. Advancements in microwave hyperthermia devices and thermotherapy technologies are driving the market forward, offering non-invasive alternatives to traditional radiation therapy. However, the high costs associated with hyperthermia therapy remain a challenge, limiting its accessibility to a larger patient population. As research and development investments continue to pour in, the market is expected to expand, providing new opportunities for cancer treatment and improving patient outcomes.
What will be the Size of the Market During the Forecast Period?
- The market is witnessing significant growth due to the increasing prevalence of cancer and the rising demand for minimally invasive and non-invasive treatments. This approach to cancer management utilizes elevated temperatures to enhance the effectiveness of conventional therapies such as radiation therapy, chemotherapy, and gene therapy. Hyperthermia treatment can be administered locally or whole-body, using various devices such as microwave, ultrasound, infrared, and shortwave hyperthermia devices. These devices are gaining popularity due to their ability to improve tumor response to conventional treatments and reduce side effects. Telemedicine and digital platforms are revolutionizing patient care in the cancer treatment landscape. Hyperthermia cancer treatment is no exception. These advancements enable remote monitoring and consultation, improving accessibility and convenience for cancer patients with low immunity.
- Similarly, screening departments are increasingly incorporating hyperthermia cancer treatment into their offerings. This is due to the potential benefits of hyperthermia in treating various types of cancers, including breast cancer, liver cancer, soft tissue sarcoma, and prostate cancer. Glass ceramics are gaining attention in the market due to their excellent bioactivity and osteoproductivity. These materials can be used to develop hyperthermia devices with improved thermal properties, ensuring efficient and effective treatment. The market is expected to grow steadily, driven by the increasing number of cancer cases and the demand for less invasive and more effective treatment options.
How is this market segmented and which is the largest segment?
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
- End-user
- Hospitals and specialty clinics
- Ambulatory surgical centers
- Research institutes
- Device
- Radiofrequency hyperthermia devices
- Microwave hyperthermia devices
- Infrared radiation hyperthermia devices
- Ultrasound based hyperthermia devices
- Geography
- North America
- Canada
- US
- Europe
- Germany
- UK
- France
- Spain
- Asia
- China
- India
- Japan
- Rest of World (ROW)
- North America
By End-user Insights
- The hospitals and specialty clinics segment is estimated to witness significant growth during the forecast period.
Hospitals and specialized clinics serve as crucial consumers in the market. The expanding accessibility of healthcare facilities, driven by initiatives like the Affordable Care Act and Medicare, contributes to the market's growth. These programs aim to offer healthcare coverage to millions of Americans, enabling them to receive advanced treatments, such as hyperthermia, for various types of tumors. As of January 2024, over 6,000 hospitals and clinics have been enrolled in these programs. This number includes approximately 1,800 private hospitals and 4,200 hospitals with more than 50 beds. The implementation of these healthcare policies has led to an increase in the adoption of minimally invasive and non-invasive treatments, including hyperthermia, which utilizes temperature-elevating devices like magnetic nanoparticles and MRI-guided electromagnetic heating.
Moreover, the integration of gene therapy and personalized medicine into cancer treatments has further boosted the market's growth. By combining hyperthermia with these advanced therapies, doctors can enhance the effectiveness of treatments and improve patient outcomes. The ongoing research and development in this field, including the exploration of new technologies like MRI-guided hyperthermia, are expected to create significant opportunities for market expansion.
Get a glance at the market report of share of various segments Request Free Sample
The hospitals and specialty clinics segment was valued at USD 64.70 million in 2018 and showed a gradual increase during the forecast period.
Regional Analysis
- North America is estimated to contribute 47% to the growth of the global market during the forecast period.
Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market share of various regions Request Free Sample
In North America, the market for hyperthermia cancer treatment is experiencing significant growth due to advanced healthcare infrastructure, substantial investment in research, and increasing awareness regarding cancer therapies. The United States and Canada are the major contributors to this market, with the U.S. leading the charge. The North American healthcare system encourages the implementation of innovative cancer treatments, such as hyperthermia, to enhance patient care. In 2023, the American Cancer Society projected over 1.9 million new cancer cases and around 609,000 cancer-related deaths in the region.
Furthermore, telemedicine and digital platforms are increasingly being utilized to expand patient access to hyperthermia cancer treatment, particularly in screening departments. Glass-ceramics with enhanced bioactivity are gaining popularity in the production of hyperthermia equipment due to their superior heat conductivity and biocompatibility. The North American market for hyperthermia cancer treatment is poised for continued growth as researchers explore new applications for this promising therapy.
Market Dynamics
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
What are the key market drivers leading to the rise in adoption of Hyperthermia Cancer Treatment Market?
Increasing research and development investments is the key driver of the market.
- The market is experiencing significant growth due to escalating investments in research and development. Hyperthermia therapy, which involves heating tumors to boost the effectiveness of other cancer treatments, is gaining prominence as a potential solution for enhancing patient outcomes when conventional methods like chemotherapy and radiation therapy fail to produce satisfactory results. This research and development activity is leading to advancements in hyperthermia technologies, enhancing the precision of targeted heat application, and integrating these treatments with innovative therapeutic approaches. Companies that specialize in developing non-invasive thermal solutions are driving progress in the hyperthermia cancer treatment sector.
- Additionally, advancements in hyperthermia technologies include the use of nanoparticles for heating, scanned focused ultrasound, and magnetite oxidation for thermal dosimetry. These technologies offer improved precision and targeted heat application, increasing the efficacy of hyperthermia treatments. Furthermore, combination therapies, such as hyperthermia in conjunction with proton therapy, are gaining popularity due to their potential to enhance treatment efficacy and reduce side effects. Hyperthermia cancer treatment is a promising area of research, with various technologies under development to improve patient outcomes. Companies are focusing on refining non-invasive thermal solutions, enhancing thermal dosimetry, and integrating hyperthermia with other therapeutic approaches. These advancements are expected to drive the growth of the market in the coming years.
What are the market trends shaping the Hyperthermia Cancer Treatment Market?
Advances in non-invasive hyperthermia is the upcoming trend in the market.
- Hyperthermia, a form of cancer treatment, is gaining popularity due to the development of non-invasive techniques. These advances in cancer management include local and whole-body hyperthermia, achieved through technologies like microwave hyperthermia devices and thermotherapy. Non-invasive hyperthermia offers several benefits, such as targeted application of heat to cancerous cells and minimal trauma to healthy tissues.
- Similarly, techniques like high-intensity focused ultrasound (HIFU) use sound waves to focus heat on tumors, enabling controlled treatment of various cancers, including prostate, liver, and breast cancer. Non-invasive hyperthermia is a viable alternative for patients unable to undergo invasive procedures due to age, medical conditions, or side effects from previous treatments. By minimizing trauma to surrounding healthy tissues, these treatments offer a more patient-friendly approach to cancer management.
What challenges does Hyperthermia Cancer Treatment Market face during the growth?
High treatment costs of hyperthermia therapy is a key challenge affecting the market growth.
- Hyperthermia cancer treatment, which involves the use of RF (Radiofrequency) and microwave technologies for internal heating, presents a promising alternative to traditional cancer therapies such as radiation and chemotherapy. However, the high cost of equipment and treatment poses a significant barrier to its widespread adoption.
- Furthermore, limited insurance coverage for hyperthermia treatments compounds the issue, as patients often bear the full cost of treatment. Clinical trials are ongoing to evaluate the efficacy and safety of hyperthermia cancer treatments, including Brachytherapy, a form of internal heating therapy. Telemedicine resources may also offer potential solutions for increasing access to hyperthermia treatments in underserved areas. Despite these challenges, the potential benefits of hyperthermia cancer treatments, such as minimally invasive, non-ionizing, and personalized treatment plans, make it a worthwhile area of exploration for cancer research and care.
Exclusive Customer Landscape
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Key Companies & Market Insights
Companies are implementing various strategies, such as strategic alliances, market forecasts, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- Andromedic Srl
- Belmont Medical Technologies
- Celsius42 GmbH
- Chongqing Haifu Medical Technology Co. Ltd.
- Combat Medical Group
- DIH Hero
- Hydrosun Medizintechnik GmbH
- Johari Digital India Ltd.
- Medtronic Plc
- ONCOTHERM KFT
- RanD SpA
- Sensius
- Therma Solutions
- Varian Medical Systems Inc.
- YAMAMOTO VINITA CO.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Research Analyst Overview
Hyperthermia cancer treatment is an emerging therapeutic approach that utilizes abnormally high temperatures to enhance the effectiveness of conventional cancer treatments. This non-invasive therapy is gaining popularity among cancer patients with low immunity due to its ability to improve tumor response and reduce side effects. Telemedicine resources and digital platforms are increasingly being used to facilitate patient care, enabling remote monitoring and consultation. Hyperthermia is applied using various techniques such as microwave, radiofrequency (RF), infrared, and ultrasound. Glass ceramics, bioactivity, and osteoconductivity are essential components in the development of temperature-elevating devices. Magnetite oxidation, hematite, and magnetic nanoparticles are used in nanoparticle heating and focused ultrasound for precise tumor targeting.
Furthermore, combination treatments, including hyperthermia, radiation therapy, chemotherapy, gene therapy, and minimally invasive procedures, are under investigation in clinical trials for breast cancer, liver cancer, soft tissue sarcoma, and prostate cancer. Hospitals, clinics, research institutes, and cancer centers are adopting hyperthermia as a locoregional and whole-body treatment for tumor shrinkage and improved radiation dose weighting. Thermal dosimetry and MRI-guided hyperthermia are essential in ensuring accurate and effective treatment delivery.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
202 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 5.9% |
|
Market growth 2024-2028 |
USD 59 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
5.5 |
|
Key countries |
US, China, Germany, UK, France, Japan, India, Canada, Spain, and Brazil |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
What are the Key Data Covered in this Market Research and Growth Report?
- CAGR of the market during the market forecast period
- Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
- Precise estimation of the size of the market and its contribution of the market in focus to the parent market
- Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
- Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
- Thorough analysis of the market's competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the growth of market companies
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch



